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Hypoxia frequently associatedwithcertain physiologicand pathologicconditionsinﬂuences numerous cellular functions.Because
the eﬀects of short-term hypoxia are incompletely understood, we examined phagocytosis and cytokine production as well as
the activation of the transcription factors HIF-1 and NFκB in peripheral blood cells of healthy volunteers exposed to an oxygen
concentrationequivalenttothatfoundataheightof5500m.Furthermore,weanalysedplasmaHIF-1andserumconcentrationsof
various HIF-1-dependent genes. Results showed that short-term hypoxia increased phagocytosis in neutrophils without aﬀecting
monocyte phagocytosis. Hypoxia decreased basal TNFα concentration in monocytes and basal interferon γ concentration in
CD4+ T lymphocytes. In contrast, plasma HIF and serum VEGF concentrations were not aﬀected by hypoxia, although serum
EPO concentration was raised. In PBMC, hypoxia increased cytosolic HIF-1 concentration without aﬀecting nuclear HIF-1
concentration and led to a rise in the nuclear NFκB in PBMC. Our results showthat short-term hypoxia aﬀects immunefunctions
in healthy individuals. Furthermore, we speculate that the eﬀe c t so fh y p o x i aa r en o td u et oH I F - 1 ,b u ta r ec a u s e db yt h ea c t i v a t i o n
of NFκB.
1.Introduction
Several physiological and pathological states can cause sys-
temic or localised tissue hypoxia and accordingly all nucle-
ated cells can sense and respond to changes in the oxygen
concentration [1] .T h eo r g a n i s m ’ sr e s p o n s et oh y p o x i a
is multifactorial involving the haematopoietic, respiratory,
and cardiovascular systems in order to maintain adequate
tissue oxygenation. However, severe hypoxia causes oxidative
stress in blood [2, 3]. Additionally, hypoxia induces a
microvascular inﬂammatory response leading to increased
vascular permeability and leukocyte-endothelial adherence
and emigration [4, 5].
Phagocytosis is important for the organism in the
defence against invading microorganisms and in ridding the
body of dead cells [6]. Phagocytes include several cell types
such as neutrophils, monocytes, macrophages, dendritic
cells, and mast cells. A disturbed phagocytosis, found in
severaldiseases, results in increased susceptibilityto bacterial
infections [7, 8]. A study by Wang and Liu carried out on
healthy volunteers exposed to a 12% oxygen concentration
demonstrated that hypoxia increased chemotaxis, phago-
cytosis and respiratory burst in leukocytes [9]. The study
group also showed that moderate exercise performed under
an oxygen concentration of 12% enhanced phagocytosis and
promoted apoptosis of neutrophils [10].
At the cellular level, the majority of genes expressed
after hypoxia are regulated by the hypoxia-inducible factor-
1 (HIF-1), a heterodimer consisting of an α and β subunit.
Under normoxic conditions, HIF-1α is rapidly degraded by2 Mediators of Inﬂammation
Table 1: Subject characteristics at baseline and under hypoxia
equivalent to a height of 5500m for 2 hours.
Normoxia Hypoxia
Age (y) 30 ±6
Height (cm) 178 ±8
Weight (kg) 75 ± 13
Heart rate (beats/min) 73 ± 98 7 ±11∗
Systolic blood pressure (mmHg) 129 ± 10 119 ±16∗
Diastolic blood pressure (mmHg) 82 ± 67 3 ±10∗
O2 saturation (%) 97 ± 27 8 ±3∗
Breathing frequency (per min) 13 ± 22 1 ±6∗
Values are mean ± SD, n = 14, ∗P<. 05 normoxia versus hypoxia.
proteasomes. However, under hypoxic conditions, HIF-1α
doesnotundergodegradation; instead, itfunctions as atran-
scription factor for various genes involved in angiogenesis,
vasomotor control, maturation of red blood cells, energy
metabolism, cell proliferation, and viability [11].
Erythropoietin (EPO), a glycoprotein that is mainly pro-
duced in the proximal tubular cells of the kidney and to a
small extent in the liver, is one of the genes regulated by HIF-
1[ 12, 13]. Whereas, under physiological conditions, EPO
regulates the manufacture of red blood cells, the production
of EPO itself is induced by a hypoxic and reduced by
hyperoxic state.
Vascular endothelial growth factor (VEGF) constitutes
another HIF-1-regulated gene. VEGF, a homodimeric, he-
parin-binding glycoprotein, has angiogenic, mitogenic, and
vascular permeability-enhancing properties especially for
endothelial cells. VEGF expression is found in activated
macrophages [14], keratinocytes [15], renal glomerular
visceral epithelium, and mesangial cells [16, 17]a sw e l la s
other cells types including many tumor cells.
In contrast to the extensive knowledge regarding phago-
cytosisofneutrophilsunderhypoxia,monocytephagocytosis
as well as cytokine expression of monocytes and T lympho-
cytes under hypoxic conditions is not well understood. For
example, mouse T lymphocytes under hypoxia showed an
increased expression of interleukin-2, -4 and interferon γ in
cell culture [18]. Dziurla et al. [19] also found an increased
expression of interleukin-2, -6, -8, -10, and -1β,a n dt h e
monocyte chemoattractant protein-1 in PMA/ionomycin
stimulated human monocytes exposed to hypoxia in vitro.
In the present study carried out on healthy volunteers
exposed to hypoxia in a specialised hypoxia chamber, we
examined for the ﬁrst time: (1) phagocytosis of neutrophils
and monocytes; (2) cytokine expression of monocytes and
CD4+ T lymphocytes; (3) serum concentrations of HIF-1,
EPO and VEGF; (4) the activation of HIF-1 and NFκBi n
peripheral blood mononuclear cells.
2.Methods
2.1. Subjects. The study was reviewed and approved by
the Ethics Committee of the Friedrich-Schiller-University,
Jena, Germany. All volunteers gave their written informed
consent. All experiments were performed according to insti-
tutional guidelines. Subjects were recruited exclusively from
the staﬀ of the Department of Internal Medicine I of
the Friedrich-Schiller-University, Jena, Germany. Fourteen
obviously healthy volunteersenrolled in thisstudy (2females
and 12 males). The characteristics at baseline and at an
oxygen tension equivalent to an altitude of 5500m are
shown in Table 1. Serum parameters between normoxia
and hypoxia were not diﬀerent despite a small tendency
towards an increased lactate concentration under hypoxic
conditions (Table 2). We did not ﬁnd a signiﬁcant diﬀerence
between the ratio of monocytes/lymphocytes/neutrophils
under normoxic or hypoxic conditions (data not shown).
2.2. Study Protocol. The study was performed in an air-
conditioned normobaric hypoxia chamber which contained
ac a r b o nd i o x i d e( C O 2) scrubber to eliminate CO2.T h e
time-dependent oxygen and concentration corresponding
height and temperature in the chamber are shown in
Figure 1. The ﬁrst blood sample was obtained following
stabilization. After 2 hours, the oxygen concentration of the
chamber was adjusted to a value equivalent to a height of
4000m. This value was maintained for 4 hours to allow for
adaption. The oxygen concentration was then adjusted to a
value equivalent to a height of 5500m to achieve hypoxic
conditions with a peripheral O2 saturation of around 75%.
A second blood sample was taken after two hours of
acclimatisation.
2.3. Blood Samples. Blood samples were collected from an
antecubital vein using a clean venipuncture under controlled
venous stasis. The ﬁrst 2mL of blood was discharged, and
the remaining blood was used to measure hematological
parameters and blood cell functions. For safety reasons, the
test was terminated immediately when a subject’s level of
O2 saturation dropped to <70%, or when the subject com-
plained of discomfort. All subjects were free of symptoms of
acute mountain sickness during the experimental period. A
100% compliance rate was obtained for the study.
2.4. O2, Heart Rate, and Blood Lactate Measurements. Pe-
ripheral O2 saturation (SaO2) was measured by means of
ﬁnger pulse oximetry (Masimo Radical-7, Masimo Corp.,
Calif, USA); blood pressure (BP) and heart rate (HR)
were monitored using an automatic blood pressure system.
Finally, capillary blood lactate was measured employing a
common blood gas analyzer (Ciba Corning 865, Chiron
Diagnostics, Norwood, Mass, USA).
2.5. Serum Electrolyte, Glucose, and Lactate Determination.
Serum electrolyte, glucose, and lactate concentrations were
determined using an ABL 800 (Radiometer, Germany).
2.6. Plasma HIF-1, Serum EPO, and VEGF Concentration.
Plasma HIF-1, serum EPO, and VEGF serum concen-
trations were determined by commercial available ELISA
(HIF-1 CUSABO113 Barksdale Professional Center Newark,Mediators of Inﬂammation 3
Table 2: Electrolytes, glucose, and lactate serum concentrations at baseline and under hypoxia equivalent to a height of 5500m for 2 hours.
KN a C aC l G l u L a c
Normoxia 4.4 ±0.7 145 ±81 .1 ±0.1 109 ±65 .4 ±0.71 .8 ±1.0
Hypoxia 4.2 ±1.0 142 ±61 .1 ±0.1 105 ±55 .1 ±0.72 .2 ±0.6
Values are mean ± SD, n = 14.
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Figure 1: Time course of oxygen concentration and corresponding
height and temperature in the hypoxia chamber during the experi-
mental period. Times of blood collections are indicated by arrows.
DE19711, EPO and VEGF RandD Systems, Germany)
according to the manufacturers’ instructions.
2.7. Phagocytotic Activity of Neutrophils and Monocytes.
FITC-labeling ofzymosan.10mgzymosan (SigmaChemicals,
Germany) were suspended by repeated soniﬁcation in 1mL
distilled H2O. 1mg FITC (Sigma Chemicals, Germany)
together with a small amount of NHCO3 (Sigma Chem-
icals, Germany) was dissolved in the zymosan solution
and incubated at 40◦C for 30min. Thereafter, the FITC-
labeled zymosan was washed three times with distilled H2O.
Zymosan particles were counted and a working solution
of 125.000particles/μL was prepared in phosphate-buﬀered
saline. To determine phagocytic activity of neutrophils and
monocytes, 500μL whole blood was mixed with 500μL
FITC-labeledzymosan withorwithoutphorbol12-myristate
13-acetate (PMA, end concentration 10−9 M, Sigma Chemi-
cals, Germany). After 20 and 60min, 200μL of this solution
were removedand erythrocyteswere lysedwith 2mL ice-cold
NH4Cl for 5min. Subsequently,FITC positively stained neu-
trophils and monocytes were determined by ﬂow cytometry.
Measuring unspeciﬁc binding of FITC-labeled zymosan was
abolished by quenching with trypan blue.
2.8. Immunoﬂuorescent Flow Cytometric Analysis of Cytokine
Production. For intracellular staining, peripheral blood was
collected in lithium-heparin tubes. 100μL blood was imme-
diately added to RPMI-1640 medium including brefeldin
A (ﬁnal concentration: 1μg/mL) and incubated for 6
hours at 37◦C under 21% oxygen with or without PMA
(concentration 10−9 M)/ionomycin (concentration 10−7 M)
(PMA/iono). All chemicals were obtained from Sigma
Chemicals, Germany. Next, erythrocytes were lysed by
NH4Cl. After washing with PBS/2% FCS, cells were stained
withmonoclonalantibodiesagainstthesurfaceantigensCD3
(Coulter-Immunotech, Krefeld, Germany) and CD4 (Caltag,
Hamburg, Germany) (15min, RT), followed by a washing
step and ﬁxation with 100μL 2% paraformaldehyde (Sigma
Chemicals, Germany) for 10min at room temperature.
After another wash, the cells were incubated in 100μL
permeabilisation solution (0.1% saponin and 0.1% NaN3
in PBS) together with 1μL directly conjugated anticytokine
antibodies(interleukin(IL)-1β,-2,-4,-5,-10,-17,interferon
γ (IFN), and tumor necrosis factor (TNF)α, all from BD-
Pharmingen, Heidelberg, Germany, for 15min at room
temperature. Followed by a second wash with permeabili-
sation solution, the cells were resuspended in PBS/2% FCS
and ﬂuorescence intensity was analysed by ﬂow cytometry
(FACSCalibur, Becton-Dickinson, Heidelberg, Germany).
Foranalysis, regions were deﬁnedby forward scatter and side
scatter. Data were analysed with CellQuest Software.
2.9. HIF-1α, p50, and p65 Activation in PBMC. Nuclear
extracts were acquired by employing the EpiQuik Nuclear
Extraction KIT I (Epigentek, NY, USA) according to the
manufacturer’s manual. Thereafter, protein concentrations
of nuclear extracts were determined according to the Brad-
ford method. For determination of HIF-1α, p50, and p65,
10μg of nuclear proteins were used. HIF-1α, p50, and p65,4 Mediators of Inﬂammation
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Figure 2: Phagocytic activity of neutrophils and monocytes. Neu-
trophils or monocytes under normoxia or hypoxia unstimulated or
stimulated with PMA were examined. Data are shown as mean ±
SEM; n = 14.
activation was determined by TransAM HIF-1 (Active Motif
Europe, Belgium) or TransAM NFκB family (Active Motif
Europe, Belgium) ELISA according to the manufacturer’s
instructions.
2.10. Statistical Analysis. All measurements are expressed as
mean ± SD, with the exception of ﬂow cytometric measure-
ments which are expressed as mean ± SEM. Diﬀerences of
a variable between hypoxia and normoxia were tested by
the paired t-test. Bivariate regression analysis is shown in
graphical form, and correlations were examined by Pearsons
correlationtest. Forstatistical analysis, WinSTAT and EXCEL
were used. A value of P<. 05 was accepted as signiﬁcant.
3.Results
3.1. Hypoxia-Induced Phagocytosis of FITC-Labeled Zymosan
in Neutrophils and Monocytes. Phagocytosis in neutrophils
and monocytes in whole blood was obtained before and
after hypoxia equivalent to an altitude of 5500m after
2h o u r s( Figure 2). The application of zymosan caused a
dramatic increase of FITC positively stained neutrophils
andmonocytesindependentofoxygenconcentration.Under
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Figure 3: Eﬀect of hypoxia and PMA/iono on the number of
monocytes or CD4+ T lymphocytes stained positive for several
cytokines determined by ﬂow cytometry. The number of cytokine
positive monocytes or CD4+ T lymphocytes was analysed by
ﬂow cytometry. n = 14; data are expressed as mean ± SEM. ∗P<
.05.
normoxia, PMA further increased the number of FITC-
positive neutrophils and monocytes. Hypoxia caused a
signiﬁcant increase of phagocytosis in neutrophils. However,
PMA did not inﬂuence this eﬀect. In monocytes, hypoxia
did not aﬀect the uptake of zymosan independent of PMA.
Moreover, we did not ﬁnd a signiﬁcant diﬀerence between
phagocytosis measured after2 0m i no ra f t e r6 0m i n .T h e s e
results demonstrate that in vivo hypoxia increased phago-
cytosis of neutrophils without inﬂuencing phagocytosis of
monocytes.
3.2. Hypoxia-Induced Cytokine Production of Monocytes and
CD4+ T lymphocytes. In the next set of experiments, we
tested whether hypoxia changed cytokine production of
monocytes and CD4+ T lymphocytes. PBMCs obtained in
normoxia and after stable hypoxia equivalent to a height of
5500m for 2 hours were used (Figure 3). In unstimulated
PBMC, hypoxia caused a decrease of TNFα in monocytes
and a decrease of IFN in CD4+ T lymphocytes. We found
no signiﬁcant changes of the other tested cytokines either in
monocytes or in CD4+ T lymphocytes after hypoxia. Stimu-
lation with PMA/iono abolished the eﬀectof hypoxia. Under
normoxic conditions, PMA/iono signiﬁcantly induced IL-4
both in monocytes and CD4+ Tl y m p h o c y t e s .
3.3. Plasma HIF-1, EPO, and VEGF Concentrations under
Hypoxia. Figure 3 shows plasma HIF-1, EPO, and VEGF
concentrations under normoxic and hypoxic conditions.
HIF-1 plasma concentration was not inﬂuenced by hypoxiaMediators of Inﬂammation 5
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Figure4:PlasmaHIF,serumEPO,andVEGFconcentrationsunder
normoxia and hypoxia. n = 14, data are expressed as mean ± SD.
∗P<. 05.
(Figure 4(a)) whereas EPO concentrations (Figure 4(b))
signiﬁcantly increased during the experiment from 6.7 ±
4.7mIU/mLto14.2 ± 7.4mIU/mL.Plasma VEGF concen-
trations (Figure 4(c)) were not inﬂuenced by short-term
hypoxia. These data indicate that in healthy volunteers
subjected to 6 hours of hypoxia in a hypoxia chamber, only
the concentration of EPO and not that of VEGF increased,
although both proteins are regulated by HIF-1. Plasma levels
of HIF-1 were not aﬀected during the experiment.
3.4. HIF-1α and NFκB Activation in PBMC by Hypoxia.
Because we found a signiﬁcant reduction of TNFα in
monocytes and INF in CD4+ T lymphocytes under hypoxia,
we examined whether HIF-1α was activated due to hypoxia.
Nuclearextracts ofPBMCundernormoxia andafterhypoxia
were prepared, and HIF-1α activity was determined with
TransAM HIF-1. Results showed no HIF-1α translocation
into the nucleus after hypoxia, although a signiﬁcantly
increased concentration of HIF-1α protein was detected in
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Figure 5: (a) Nuclear HIF-1α activity of PBMC under normoxia
and after hypoxia. (b) Cytosolic HIF-1α c o n c e n t r a t i o ni nP B M C .
n = 14, data are expressed as mean ± SD.
the cytosol following hypoxia. Our data indicate that under
mild hypoxia, PBMC synthesis increased HIF-1α protein
in the cytosol whereas translocation into the nucleus was
not increased (Figure 5). Because hypoxia is also capable
of activating the NFκBp a t h w a y ,w ee x a m i n e dw h e t h e r
our experimental conditions caused activation of p50 or
p65. For this purpose, nuclear extracts of normoxic or
hypoxic PBMC were analyzed using the TransAM NFκB
family ELISA.In PBMC,hypoxiacaused asigniﬁcant nuclear
translocation of p50 whereas p65 increased under hypoxia
but did not reach signiﬁcance (Figure 6) indicating that an
oxygen concentration of 10% in the air caused an activation
of the NFκBp a t h w a y .
3.5. Serum Lactate Concentrations Correlate with Phagocytosis
in Neutrophils and INF Expression in CD4+ T Lymphocytes.
We performed a correlation analysis and found a linear
relation between the hypoxia/normoxia ratio of lactate
concentrations and the hypoxia/normoxia ratio of phago-
cytosis of neutrophils measured by FITC-labeled zymosan
incorporation (Y = 0.241X +1 .023, R2 = 0.234, P =
.040) (Figure 7(a)) and between the ratio of serum lactate
concentrationand theratio oftheexpression ofINFinCD4+
Tl y m p h o c y t e s( Y = 0.869X − 0.452, R2 = 0.401, P =
.007) (Figure 7(b)). This data indicates that despite serum
lactate concentrations always being in a normal range, the
lactate hypoxia/normoxia ratio correlated with neutrophil
phagocytosis independent of PMA stimulation and INF
expression in CD4+ T lymphocytes. We did not ﬁnd any
correlation between the other determined variables.6 Mediators of Inﬂammation
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Figure 6: (a)Nuclear p50activationinPBMCunder normoxiaand
a f t e rh y p o x i a .( b )N u c l e a rp 6 5a c t i v a t i o nP B M Cu n d e rn o r m o x i a
and after hypoxia. n = 14; data are expressed as mean ± SD.
4.Discussion
The present study provides new insights into the eﬀects of
hypoxiaonphagocytosis,cytokineexpression, and transcrip-
tion factor activation in peripheral blood cells.
Short-termhypoxia, equivalenttoa height of5500mina
normobaric hypoxia chamber, did increase EPO concentra-
tion signiﬁcantly without aﬀecting plasma HIF-1 or serum
VEGF concentrations. We found a considerable variability
of plasma HIF-1 induction by hypoxia ranging from 0.13 to
21.0 fold. The fact that we did not ﬁnd HIF-1 activation in
PBMC is in good agreement with data published by Jiang et
al.[20].ThisgroupdeterminedasigniﬁcantHIF-1activation
with oxygen concentrations below 10% in HeLa cells, an
oxygen concentration value not achieved in our experiment.
Our results also conﬁrm data published by Mounier et al.
in 2009 [21], who examined the concentration of HIF-1α
mRNA in leukocytes, serum EPO concentration, and plasma
VEGF concentration after hypoxia induced in a hypoxia
chamberwithanoxygenconcentrationequivalenttoaheight
of 3000m in endurance athletes. Under these conditions,
HIF-1α mRNA was signiﬁcantly increased in leukocytes and
serum EPO concentrations were increased whereas VEGF
decreased. Similar eﬀects of hypoxia on leukocyte HIF-1
DNA binding and protein concentration were observed by
T i s s o tv a nP a t o te ta l .i nah y p o x i ac h a m b e r[ 22]. In the
present study, we found a signiﬁcant increase of HIF-1
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Figure 7: Correlation analysis determined a linear regression
between (a) the lactate hypoxia/lactate normoxia ratio and the
phagocytosis hypoxia/phagocytosis normoxia ratio in neutrophils,
(b) the lactate hypoxia/lactate normoxia ratio and the intracellular
INF hypoxia/intracellular INF normoxia ratio in CD4+ Tl y m p h o -
cytes.
protein in the PBMC cytosol, although no increase of HIF-
1 protein in the nucleus was observed indicating that under
hypoxia, despite an increase of cytosolic HIF-1, protein
translocation in the nucleus is separately regulated. Because
leukocytes were examined in the former studies and PBMC
in our study, we speculate that the eﬀect of hypoxia on blood
cells may be similar in all cell types.
Mounting evidence over the last few years points to
an association between the HIF and NFκBp a t h w a y s .T h e
inhibition of oxygen-dependent hydroxylases under hypoxic
conditions results in several consequences. On the one
hand, phosphorylation of IκB mediates the activation of
p50/p65, and, on the other hand, this prevents HIF-1α from
undergoing a proteasomal degradation that would lead to
increased concentrations of HIF-1α.S i n c eaN F κBb i n d i n g
site is present in the promoter for the HIF-1α gene, NFκB
can increase HIF-1α mRNA and protein [23, 24]. Indeed, we
found a raised activation of the NFκB pathway in hypoxic
PBMC of healthy volunteers as well as an increased cytosolic
HIF-1concentrationwhich maybeexplainedbythecrosstalk
between NFκB and HIF-1. Nevertheless, this crosstalk doesMediators of Inﬂammation 7
notaccount fortheobservationthat increased cytosolicHIF-
1 levels were not followed by an increase in HIF-1 nuclear
concentration. Thus, we speculate that translocation of HIF-
1α into the nucleus is also regulated and was not apparent
underourexperimental conditions.Afurtherregulatorystep
in HIF-1α-induced gene expression may also explain the
fact that under hypoxia we found only TNFα decreased in
monocytes and IFN in CD4+ T lymphocytes whereas all
other tested cytokines were not aﬀected by hypoxia.
A sH I F - 1i sa b l et or e g u l a t eE P Oa n dV E G Fe x p r e s s i o n ,
we examined these concentrations underhypoxia. Compara-
ble to Mounier et al. [21]a n dE c k a r d te ta l .[ 25], we found
a signiﬁcant increase in serum EPO concentration after
hypoxia. Whilst Mounier described a signiﬁcant decrease
of plasma VEGF concentration after 3h, we noted only a
modest and not a signiﬁcant reduction in serum VEGF
levels. This discrepancy might be attributed to the duration
of hypoxia or even to the number of volunteers which
was too small to reach signiﬁcance and awaits further
investigation. Finally, comparable to other investigators [25–
27], our results revealed a marked individual variation of the
serumEPOconcentrationunderhypoxia(increaseof1.44-to
21.18-fold by hypoxia) indicating an individual response to
hypoxia.
Phagocytosis by macrophages and neutrophils is the
organism’s ﬁrst line of defence against bacterial infection.
Systemic inﬂammatory diseases are characterised by the
development of hypoxia, a process in which clearance of
bacteria is of particular importance. For example, hypoxia
often develops subsequent to major burns [28], trauma
[29], and pancreatitis [30], often followed by a bacterial
superinfection. This clinical observation may suggest that
hypoxia is critical in phagocytosis. Anand et al. showed in
mouse macrophages [31] that under hypoxia, phagocytosis
increases, is positively regulated by p38 phosphorylation
and augments HIF-1α expression. In the present study,
systemic hypoxia caused an increase in phagocytosis in
neutrophils as measured by the uptake of FITC-labeled
zymosan. Our results are in good agreement with Wang
and Chiu [10] who clearly demonstrated that under hypoxic
conditions phagocytosis in neutrophils as well as chemotaxis
and ROS production is enhanced. Increased phagocytosis
of neutrophils may be a counterregulatory process to clean
hypoxic areas from invading organisms.
The explanation relating to in vivo monocyte and CD4+
T lymphocyte cytokine production under hypoxic condi-
tions provides a slight diﬃculty. Oxygen concentrations
equivalent to a height of 5500m for 2 hours caused a
decrease of both TNFα in monocytes and INF in CD4+
Tl y m p h o c y t e si no u rs u b j e c t sa sa n a l y s e du s i n gF A C S .
We used a cytokine array which is able to distinguish
between a Th1- and Th2-inﬂammatory response in CD4+ T
lymphocytes.Underhypoxia, we founda nonsigniﬁcant shift
to a Th2-inﬂammatory response in CD4+ Tl y m p h o c y t e s .
The fact that after stimulation with PMA/iono this response
is abolished showed that hypoxia did not alter cellular T-
cell activation. Thus, our in vivo results are in contrast to
former in vitro studies. Ghezzi et al. [32]f o u n da ni n c r e a s e d
secretion of TNFα,I L - 1 α,a n dI L - 1 β after severe hypoxia and
NFκB activation HIF-1α
Hypoxia
Hydroxylase activity
Nucleus:
p50/p65
This step is regulated
independently
Figure 8: Proposed mechanism of hypoxia on HIF-1 and NFκB
activation in PBMC. Hypoxia causes a reduction of hydroxylase
activity leading on the one hand to the activation of NFκBa n d
a consecutive transport of the p50/p65 complex into the nucleus.
Bindingofp50/p65 to the corresponding promotorside ofthe HIF-
1α g e n er e s u l t si na ni n c r e a s eo fH I F - 1 α protein in the cytosol.
On the other hand, reduced hydroxylase activity prevents HIF-
1α degradation by the proteasome increasing cytosolic HIF-1α
concentration. Under hypoxic conditions equivalent to a height of
5500m, an increase of cytosolic HIF-1α did not raise the HIF-1α
concentration in the nucleus indicating that not only the HIF-1
concentration in the cytosol, but alsothe transport into the nucleus
is regulated.
stimulation with PMA in PBMC of healthy volunteers. It
was concludedthat hypoxia renders PBMC more susceptible
to external stimuli. But these authors did not diﬀerentiate
between monocytes and lymphocytes in their experiments.
An aggravating eﬀect of TNFα production by hypoxia
was also reported by Demasi et al. [33], who found an
increased TNFα synthesis in LPS-stimulated monocytes of
healthy blood donors under hypoxic culture conditions. In
T lymphocytes of diﬀerent mouse strains, Roman et al.
[18] described an increased IFN production after activation
with antibodies against CD3 and CD28 in severe hypoxia.
Interestingly, this increase in INF production was also
observedinTlymphocytesofmousestrains lackingonecopy
o ft h eg e n ee n c o d i n gH I F - 1 α indicating that this increase is
independent of HIF-1α activation.
Taken together, most published studies show that
hypoxia in in vitro sensitized monocytes and T-lymphocytes
represents an activating stimulas resulting in increased pro-
duction of inﬂammatory cytokines. Though discrepancies
relating to cytokine production are apparent, these can
be explained by the fact that most groups used PBMC,
monocytes or CD4+ T lymphocytes of healthy donors which
were incubated in cell cultures under hypoxic conditions.
We, in contrast, used PBMC from healthy donors who
were exposed to hypoxia in a hypoxia chamber for several
hours. The PBMCs were subsequently incubated for 6h
under normoxic conditions without or with PMA/iono.
The very diﬀerent experimental settings may lead to the
diﬀerent cellular behaviour following the stimulation of
PMBC. Finally, our results are in good agreement with a
study published by Dziurla et al. [19]. Similar to our data,
the authors found a signiﬁcant decrease of TNFα in CD4+
T lymphocytes, although the eﬀect of CD4+ Tl y m p h o c y t e8 Mediators of Inﬂammation
productionofINFwasnottestedbythisgroup.Underinvivo
conditions, glucose, which has a negative eﬀect on cytokine
production [19], is not involved since we could show that
under short-term hypoxia in a hypoxia chamber, glucose
concentration was not aﬀected.
Taken together, our study demonstrates that moderate
short-term systemic hypoxia (1) increases phagocytosis in
neutrophils and not in monocytes, (2) diminishes TNFα
production in monocytes and INF production in CD4+
T lymphocytes, (3) increases HIF-1α protein expression
in PBMC without translocationi n t ot h en u c l e u s ,a n d( 4 )
activates the NFκB pathway in these cells. In addition, the
proposed eﬀect of hypoxia in PBMC on HIF-1α and NFκB
pathway activation was demonstrated in the current study
and supports the crosstalk between HIF and NFκB signaling
in short-term hypoxia
Thus, we hypothesise that the eﬀects of hypoxia under
our experimental setting were due to NFκBa c t i v a t i o n .
Furthermore, our results suggest that in mild short-term
hypoxia, HIF-1 translocation into the nucleus is separately
regulated (Figure 8).
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